Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.49565778 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.49565778 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.26435891 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.43951286 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00191464 |
6 | detection of other organism (GO:0098543) | 4.70521946 |
7 | response to type I interferon (GO:0034340) | 4.62639025 |
8 | cellular response to type I interferon (GO:0071357) | 4.59476119 |
9 | type I interferon signaling pathway (GO:0060337) | 4.59476119 |
10 | positive regulation of interferon-alpha production (GO:0032727) | 4.56169212 |
11 | negative regulation of interleukin-12 production (GO:0032695) | 4.48456285 |
12 | detection of bacterium (GO:0016045) | 4.40115717 |
13 | detection of molecule of bacterial origin (GO:0032490) | 4.39943251 |
14 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.37604503 |
15 | regulation of interferon-alpha production (GO:0032647) | 4.35830733 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24311002 |
17 | modulation by symbiont of host defense response (GO:0052031) | 4.24311002 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24311002 |
19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24311002 |
20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24311002 |
21 | modulation by symbiont of host immune response (GO:0052553) | 4.24311002 |
22 | detection of external biotic stimulus (GO:0098581) | 4.22155490 |
23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.08383733 |
24 | T cell migration (GO:0072678) | 4.05693287 |
25 | negative thymic T cell selection (GO:0045060) | 4.04532735 |
26 | negative regulation of cell killing (GO:0031342) | 3.98453502 |
27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98453502 |
28 | immunoglobulin mediated immune response (GO:0016064) | 3.98252152 |
29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.96820405 |
30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92407948 |
31 | microglial cell activation (GO:0001774) | 3.92321853 |
32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90298798 |
33 | negative T cell selection (GO:0043383) | 3.89373594 |
34 | neutrophil activation involved in immune response (GO:0002283) | 3.88427001 |
35 | NIK/NF-kappaB signaling (GO:0038061) | 3.87322154 |
36 | positive regulation of mast cell activation (GO:0033005) | 3.86305138 |
37 | regulation of T cell tolerance induction (GO:0002664) | 3.80301535 |
38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.79369333 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78548968 |
40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.76778657 |
41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.74508777 |
42 | detection of biotic stimulus (GO:0009595) | 3.73724497 |
43 | positive thymic T cell selection (GO:0045059) | 3.68580461 |
44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68247481 |
45 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.67926412 |
46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.67296865 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.63964785 |
48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61520400 |
49 | regulation of mast cell degranulation (GO:0043304) | 3.61304747 |
50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.59836097 |
51 | leukocyte aggregation (GO:0070486) | 3.59151743 |
52 | macrophage activation (GO:0042116) | 3.54370870 |
53 | response to peptidoglycan (GO:0032494) | 3.52138465 |
54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.49387594 |
55 | positive regulation of mast cell degranulation (GO:0043306) | 3.49387594 |
56 | positive regulation of interferon-beta production (GO:0032728) | 3.39263477 |
57 | neutrophil activation (GO:0042119) | 3.38474772 |
58 | cellular response to interferon-beta (GO:0035458) | 3.36056803 |
59 | myeloid dendritic cell activation (GO:0001773) | 3.36043225 |
60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.35255196 |
61 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.35116681 |
62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.34255220 |
63 | regulation of mast cell activation (GO:0033003) | 3.33928283 |
64 | myeloid dendritic cell differentiation (GO:0043011) | 3.33590560 |
65 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.33349487 |
66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32387259 |
67 | macrophage activation involved in immune response (GO:0002281) | 3.30348005 |
68 | granulocyte activation (GO:0036230) | 3.30264069 |
69 | regulation of antigen processing and presentation (GO:0002577) | 3.29896720 |
70 | defense response to protozoan (GO:0042832) | 3.28896085 |
71 | natural killer cell mediated immunity (GO:0002228) | 3.27025754 |
72 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.27025754 |
73 | regulation of leukocyte degranulation (GO:0043300) | 3.26591664 |
74 | respiratory burst (GO:0045730) | 3.26046010 |
75 | regulation of RIG-I signaling pathway (GO:0039535) | 3.25883613 |
76 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.25842104 |
77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.23794821 |
78 | response to muramyl dipeptide (GO:0032495) | 3.23757899 |
79 | thymic T cell selection (GO:0045061) | 3.22629966 |
80 | positive regulation of tolerance induction (GO:0002645) | 3.21380584 |
81 | regulation of B cell differentiation (GO:0045577) | 3.20720566 |
82 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.20511817 |
83 | B cell receptor signaling pathway (GO:0050853) | 3.19884852 |
84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19381613 |
85 | tolerance induction (GO:0002507) | 3.18435896 |
86 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.17004831 |
87 | B cell mediated immunity (GO:0019724) | 3.16818322 |
88 | response to interferon-alpha (GO:0035455) | 3.16374689 |
89 | T cell selection (GO:0045058) | 3.15832242 |
90 | positive regulation of B cell differentiation (GO:0045579) | 3.13863665 |
91 | response to interleukin-15 (GO:0070672) | 3.11296389 |
92 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11255482 |
93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11227044 |
94 | regulation of tolerance induction (GO:0002643) | 3.10801334 |
95 | positive regulation of isotype switching (GO:0045830) | 3.10544016 |
96 | positive regulation of interleukin-12 production (GO:0032735) | 3.10139530 |
97 | cellular response to interferon-gamma (GO:0071346) | 3.09082406 |
98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08830039 |
99 | response to host immune response (GO:0052572) | 3.08830039 |
100 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.08717464 |
101 | response to protozoan (GO:0001562) | 3.07909406 |
102 | activated T cell proliferation (GO:0050798) | 3.04611429 |
103 | regulation of response to interferon-gamma (GO:0060330) | 3.03637567 |
104 | positive regulation of interleukin-2 production (GO:0032743) | 3.01942008 |
105 | positive regulation of humoral immune response (GO:0002922) | 3.01352983 |
106 | cellular response to virus (GO:0098586) | 3.01334631 |
107 | cellular response to zinc ion (GO:0071294) | 2.99623024 |
108 | neutrophil mediated immunity (GO:0002446) | 2.99096577 |
109 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.97873489 |
110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96662160 |
111 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95489487 |
112 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95295990 |
113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93681636 |
114 | positive regulation of type 2 immune response (GO:0002830) | 2.92197518 |
115 | leukocyte cell-cell adhesion (GO:0007159) | 2.91656861 |
116 | interferon-gamma production (GO:0032609) | 2.91363607 |
117 | positive regulation of leukocyte degranulation (GO:0043302) | 2.90668438 |
118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89531145 |
119 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.88617198 |
120 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87594041 |
121 | positive T cell selection (GO:0043368) | 2.86779219 |
122 | regulation of interleukin-12 production (GO:0032655) | 2.86676721 |
123 | myeloid cell activation involved in immune response (GO:0002275) | 2.84999739 |
124 | cellular extravasation (GO:0045123) | 2.84743665 |
125 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84188679 |
126 | response to host (GO:0075136) | 2.84188679 |
127 | response to host defenses (GO:0052200) | 2.84188679 |
128 | response to interferon-beta (GO:0035456) | 2.83451441 |
129 | negative regulation of viral genome replication (GO:0045071) | 2.82912503 |
130 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82834076 |
131 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.82325032 |
132 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.79694396 |
133 | myeloid leukocyte activation (GO:0002274) | 2.79385922 |
134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78640439 |
135 | dendritic cell migration (GO:0036336) | 2.77230470 |
136 | regulation of hypersensitivity (GO:0002883) | 2.75595650 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.70969309 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.69598168 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.44177506 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.82372858 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65281749 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.28268756 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67256095 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31275150 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30416580 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.25337926 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24870068 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15615997 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10508714 |
14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07726381 |
15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98868871 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65989686 |
17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60932380 |
18 | MYB_26560356_Chip-Seq_TH2_Human | 2.51955540 |
19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.45482983 |
20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.40922553 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.38347363 |
22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.37101659 |
23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.37046469 |
24 | MYB_26560356_Chip-Seq_TH1_Human | 2.17962777 |
25 | MYC_22102868_ChIP-Seq_BL_Human | 2.14960957 |
26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14904327 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06398821 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01658880 |
29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01545374 |
30 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97073108 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89033550 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87269951 |
33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85812101 |
34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80560039 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79701778 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76491955 |
37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75626527 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70178350 |
39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64573563 |
40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59247360 |
41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58646638 |
42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53649661 |
43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52882849 |
44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52641572 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52559068 |
46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52426080 |
47 | MAF_26560356_Chip-Seq_TH2_Human | 1.52287901 |
48 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49631457 |
49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49582671 |
50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47401781 |
51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46383433 |
52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39713092 |
53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38082564 |
54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33767046 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32790242 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28522642 |
57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22768590 |
58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21867698 |
59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21761530 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20727777 |
61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18221964 |
62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16957502 |
63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13886285 |
64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13721460 |
65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11478025 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10911207 |
67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08283481 |
68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07556647 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05760416 |
70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05500485 |
71 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05063531 |
72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04363888 |
73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02914729 |
74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02310416 |
75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02269691 |
76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02159057 |
77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01047472 |
78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00129502 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98539659 |
80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98371654 |
81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98349516 |
82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97217194 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96441084 |
84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94609765 |
85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92251097 |
86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91995459 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88931161 |
88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86792959 |
89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85528149 |
90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85169485 |
91 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84889071 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84794154 |
93 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.84589942 |
94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83771813 |
95 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82345434 |
96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82268121 |
97 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81106049 |
98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79681382 |
99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78923917 |
100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77769779 |
101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77675932 |
102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76238870 |
103 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75068254 |
104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74981256 |
105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74560446 |
106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74150592 |
107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73535710 |
108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73067786 |
109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71855345 |
110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.71431917 |
111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70929751 |
112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65207769 |
113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.64553476 |
114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.64553476 |
115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.64284028 |
116 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.63397154 |
117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62111621 |
118 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.61959560 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.72065159 |
2 | MP0000685_abnormal_immune_system | 3.48957468 |
3 | MP0005387_immune_system_phenotype | 3.43205260 |
4 | MP0001790_abnormal_immune_system | 3.43205260 |
5 | MP0003436_decreased_susceptibility_to | 3.31497559 |
6 | MP0009785_altered_susceptibility_to | 3.27852751 |
7 | MP0005671_abnormal_response_to | 3.23129746 |
8 | MP0001800_abnormal_humoral_immune | 3.18123745 |
9 | MP0003303_peritoneal_inflammation | 3.12470447 |
10 | MP0005000_abnormal_immune_tolerance | 3.06734902 |
11 | MP0002452_abnormal_antigen_presenting | 2.89302883 |
12 | MP0002148_abnormal_hypersensitivity_rea | 2.88551388 |
13 | MP0004510_myositis | 2.87608423 |
14 | MP0005025_abnormal_response_to | 2.82411448 |
15 | MP0002723_abnormal_immune_serum | 2.75443384 |
16 | MP0002419_abnormal_innate_immunity | 2.65347709 |
17 | MP0006082_CNS_inflammation | 2.59277881 |
18 | MP0001819_abnormal_immune_cell | 2.58083715 |
19 | MP0002420_abnormal_adaptive_immunity | 2.56713690 |
20 | MP0003763_abnormal_thymus_physiology | 2.42092033 |
21 | MP0002166_altered_tumor_susceptibility | 2.34227270 |
22 | MP0003724_increased_susceptibility_to | 2.30912892 |
23 | MP0002398_abnormal_bone_marrow | 2.16600381 |
24 | MP0002405_respiratory_system_inflammati | 2.09065345 |
25 | MP0000716_abnormal_immune_system | 2.06705958 |
26 | MP0002006_tumorigenesis | 2.06680801 |
27 | MP0004947_skin_inflammation | 2.02309726 |
28 | MP0003300_gastrointestinal_ulcer | 1.97706836 |
29 | MP0010155_abnormal_intestine_physiology | 1.93580700 |
30 | MP0001853_heart_inflammation | 1.89624603 |
31 | MP0005464_abnormal_platelet_physiology | 1.86069912 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.84387081 |
33 | MP0008260_abnormal_autophagy | 1.83022570 |
34 | MP0001845_abnormal_inflammatory_respons | 1.81826608 |
35 | MP0001533_abnormal_skeleton_physiology | 1.75967678 |
36 | MP0000689_abnormal_spleen_morphology | 1.75733667 |
37 | MP0002429_abnormal_blood_cell | 1.68957900 |
38 | MP0002722_abnormal_immune_system | 1.67866213 |
39 | MP0003448_altered_tumor_morphology | 1.67281548 |
40 | MP0005058_abnormal_lysosome_morphology | 1.67010043 |
41 | MP0001873_stomach_inflammation | 1.65717244 |
42 | MP0002396_abnormal_hematopoietic_system | 1.65030835 |
43 | MP0004883_abnormal_blood_vessel | 1.59381332 |
44 | MP0005310_abnormal_salivary_gland | 1.57141554 |
45 | MP0005451_abnormal_body_composition | 1.56604714 |
46 | MP0003690_abnormal_glial_cell | 1.50612381 |
47 | MP0009278_abnormal_bone_marrow | 1.48114640 |
48 | MP0008469_abnormal_protein_level | 1.45102537 |
49 | MP0000858_altered_metastatic_potential | 1.43032838 |
50 | MP0004808_abnormal_hematopoietic_stem | 1.39545268 |
51 | MP0000703_abnormal_thymus_morphology | 1.36794313 |
52 | MP0000569_abnormal_digit_pigmentation | 1.36167553 |
53 | MP0001545_abnormal_hematopoietic_system | 1.36023768 |
54 | MP0005397_hematopoietic_system_phenotyp | 1.36023768 |
55 | MP0009764_decreased_sensitivity_to | 1.35484879 |
56 | MP0002138_abnormal_hepatobiliary_system | 1.35229090 |
57 | MP0002933_joint_inflammation | 1.32829817 |
58 | MP0008004_abnormal_stomach_pH | 1.23092283 |
59 | MP0002998_abnormal_bone_remodeling | 1.20775719 |
60 | MP0002132_abnormal_respiratory_system | 1.19330686 |
61 | MP0000343_altered_response_to | 1.16822479 |
62 | MP0003866_abnormal_defecation | 1.16442606 |
63 | MP0005076_abnormal_cell_differentiation | 1.14873069 |
64 | MP0010352_gastrointestinal_tract_polyps | 1.10806578 |
65 | MP0010307_abnormal_tumor_latency | 1.10629897 |
66 | MP0002277_abnormal_respiratory_mucosa | 1.08371192 |
67 | MP0003172_abnormal_lysosome_physiology | 1.08369401 |
68 | MP0001851_eye_inflammation | 1.06318273 |
69 | MP0000465_gastrointestinal_hemorrhage | 1.02444395 |
70 | MP0003566_abnormal_cell_adhesion | 1.02274447 |
71 | MP0003191_abnormal_cellular_cholesterol | 0.95529128 |
72 | MP0004381_abnormal_hair_follicle | 0.94423147 |
73 | MP0005174_abnormal_tail_pigmentation | 0.92617416 |
74 | MP0000490_abnormal_crypts_of | 0.91284539 |
75 | MP0002254_reproductive_system_inflammat | 0.89155184 |
76 | MP0003091_abnormal_cell_migration | 0.88095845 |
77 | MP0003453_abnormal_keratinocyte_physiol | 0.87099830 |
78 | MP0003656_abnormal_erythrocyte_physiolo | 0.86887784 |
79 | MP0005023_abnormal_wound_healing | 0.85081081 |
80 | MP0000604_amyloidosis | 0.83997691 |
81 | MP0005390_skeleton_phenotype | 0.81173253 |
82 | MP0009763_increased_sensitivity_to | 0.80804619 |
83 | MP0003045_fibrosis | 0.80354001 |
84 | MP0009840_abnormal_foam_cell | 0.79791403 |
85 | MP0002019_abnormal_tumor_incidence | 0.79789221 |
86 | MP0002009_preneoplasia | 0.78714625 |
87 | MP0003806_abnormal_nucleotide_metabolis | 0.78433311 |
88 | MP0005166_decreased_susceptibility_to | 0.74706475 |
89 | MP0003075_altered_response_to | 0.71902108 |
90 | MP0003329_amyloid_beta_deposits | 0.69626849 |
91 | MP0000249_abnormal_blood_vessel | 0.68018735 |
92 | MP0000920_abnormal_myelination | 0.66665512 |
93 | MP0001958_emphysema | 0.65930404 |
94 | MP0002136_abnormal_kidney_physiology | 0.64773145 |
95 | MP0005075_abnormal_melanosome_morpholog | 0.64251809 |
96 | MP0004130_abnormal_muscle_cell | 0.63621927 |
97 | MP0003795_abnormal_bone_structure | 0.63277495 |
98 | MP0005164_abnormal_response_to | 0.63060040 |
99 | MP0004782_abnormal_surfactant_physiolog | 0.61027982 |
100 | MP0002332_abnormal_exercise_endurance | 0.60828400 |
101 | MP0000767_abnormal_smooth_muscle | 0.60485154 |
102 | MP0003828_pulmonary_edema | 0.59304777 |
103 | MP0003279_aneurysm | 0.59300167 |
104 | MP0000371_diluted_coat_color | 0.59283954 |
105 | MP0003183_abnormal_peptide_metabolism | 0.58812982 |
106 | MP0006054_spinal_hemorrhage | 0.58432422 |
107 | MP0001986_abnormal_taste_sensitivity | 0.58033209 |
108 | MP0005388_respiratory_system_phenotype | 0.57349400 |
109 | MP0002133_abnormal_respiratory_system | 0.57349400 |
110 | MP0009115_abnormal_fat_cell | 0.56438259 |
111 | MP0001663_abnormal_digestive_system | 0.56022631 |
112 | MP0008874_decreased_physiological_sensi | 0.55627058 |
113 | MP0000015_abnormal_ear_pigmentation | 0.54095300 |
114 | MP0001348_abnormal_lacrimal_gland | 0.51859048 |
115 | MP0001881_abnormal_mammary_gland | 0.51435955 |
116 | MP0008438_abnormal_cutaneous_collagen | 0.49895122 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.48624797 |
118 | MP0008057_abnormal_DNA_replication | 0.48201449 |
119 | MP0000627_abnormal_mammary_gland | 0.46806446 |
120 | MP0005621_abnormal_cell_physiology | 0.45791035 |
121 | MP0000313_abnormal_cell_death | 0.44576079 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.01464904 |
2 | Recurrent abscess formation (HP:0002722) | 5.67777577 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.28144171 |
4 | Chronic otitis media (HP:0000389) | 5.04114429 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56275928 |
6 | Recurrent fungal infections (HP:0002841) | 4.51978114 |
7 | Recurrent viral infections (HP:0004429) | 4.41660834 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 4.31175098 |
9 | Myositis (HP:0100614) | 4.24724173 |
10 | Recurrent bronchitis (HP:0002837) | 4.14961586 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 4.13825897 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.06049635 |
13 | Nasal polyposis (HP:0100582) | 4.02525302 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.96968176 |
15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.96968176 |
16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.96968176 |
17 | Abnormality of macrophages (HP:0004311) | 3.84929240 |
18 | Recurrent skin infections (HP:0001581) | 3.82046252 |
19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.72557819 |
20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.72557819 |
21 | Vasculitis (HP:0002633) | 3.65952296 |
22 | Abnormality of the nasal mucosa (HP:0000433) | 3.64641504 |
23 | Orchitis (HP:0100796) | 3.59125176 |
24 | Abnormality of T cell number (HP:0011839) | 3.55116546 |
25 | Pustule (HP:0200039) | 3.52860554 |
26 | T lymphocytopenia (HP:0005403) | 3.44073223 |
27 | Optic neuritis (HP:0100653) | 3.39334169 |
28 | Retrobulbar optic neuritis (HP:0100654) | 3.39334169 |
29 | Amyloidosis (HP:0011034) | 3.37722957 |
30 | Stomatitis (HP:0010280) | 3.35653782 |
31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.35256162 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.31679805 |
33 | Obstructive lung disease (HP:0006536) | 3.31679805 |
34 | Cellulitis (HP:0100658) | 3.29651591 |
35 | Gingivitis (HP:0000230) | 3.20111594 |
36 | Increased IgM level (HP:0003496) | 3.16614017 |
37 | Spontaneous hematomas (HP:0007420) | 3.12931038 |
38 | Abnormality of T cells (HP:0002843) | 3.11851582 |
39 | Meningitis (HP:0001287) | 3.07612863 |
40 | IgM deficiency (HP:0002850) | 3.01318028 |
41 | Chronic sinusitis (HP:0011109) | 2.99087234 |
42 | Agammaglobulinemia (HP:0004432) | 2.98672962 |
43 | Interstitial pulmonary disease (HP:0006530) | 2.95112515 |
44 | Periodontitis (HP:0000704) | 2.94416721 |
45 | Inflammation of the large intestine (HP:0002037) | 2.91855396 |
46 | Increased IgE level (HP:0003212) | 2.87565136 |
47 | Pulmonary infiltrates (HP:0002113) | 2.87440659 |
48 | Colitis (HP:0002583) | 2.82950176 |
49 | Panhypogammaglobulinemia (HP:0003139) | 2.80200477 |
50 | Loss of speech (HP:0002371) | 2.77261982 |
51 | Hypergammaglobulinemia (HP:0010702) | 2.77131456 |
52 | Leukocytosis (HP:0001974) | 2.77028164 |
53 | Gastrointestinal inflammation (HP:0004386) | 2.76258361 |
54 | Abnormality of the fingertips (HP:0001211) | 2.74044359 |
55 | Eosinophilia (HP:0001880) | 2.73028054 |
56 | Abnormality of T cell physiology (HP:0011840) | 2.72565620 |
57 | Autoimmune hemolytic anemia (HP:0001890) | 2.71686171 |
58 | Emphysema (HP:0002097) | 2.70276405 |
59 | Systemic lupus erythematosus (HP:0002725) | 2.68191928 |
60 | Lymphopenia (HP:0001888) | 2.68080299 |
61 | Dysostosis multiplex (HP:0000943) | 2.66534914 |
62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.65097636 |
63 | Gastrointestinal infarctions (HP:0005244) | 2.62775648 |
64 | Hemoptysis (HP:0002105) | 2.62002261 |
65 | Hematochezia (HP:0002573) | 2.59792751 |
66 | IgA deficiency (HP:0002720) | 2.59625891 |
67 | Gastrointestinal stroma tumor (HP:0100723) | 2.59293579 |
68 | Osteomyelitis (HP:0002754) | 2.58485662 |
69 | Pulmonary embolism (HP:0002204) | 2.57514307 |
70 | Vacuolated lymphocytes (HP:0001922) | 2.56606179 |
71 | Prolonged bleeding time (HP:0003010) | 2.51439626 |
72 | IgG deficiency (HP:0004315) | 2.48937041 |
73 | Arterial thrombosis (HP:0004420) | 2.46618362 |
74 | Osteolytic defects of the hand bones (HP:0009699) | 2.45961683 |
75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45961683 |
76 | Granulocytopenia (HP:0001913) | 2.43864721 |
77 | Gingival bleeding (HP:0000225) | 2.42782006 |
78 | Recurrent pneumonia (HP:0006532) | 2.40091932 |
79 | Increased cerebral lipofuscin (HP:0011813) | 2.39396419 |
80 | Recurrent lower respiratory tract infections (HP:0002783) | 2.36107197 |
81 | Abnormality of eosinophils (HP:0001879) | 2.35501587 |
82 | Purpura (HP:0000979) | 2.35101333 |
83 | Skin ulcer (HP:0200042) | 2.33595294 |
84 | Petechiae (HP:0000967) | 2.32727252 |
85 | Bronchitis (HP:0012387) | 2.29239626 |
86 | Urticaria (HP:0001025) | 2.28718502 |
87 | Peritonitis (HP:0002586) | 2.28690406 |
88 | Thick nail (HP:0001805) | 2.27491371 |
89 | Thrombocytosis (HP:0001894) | 2.24500768 |
90 | Gangrene (HP:0100758) | 2.24138311 |
91 | Encephalitis (HP:0002383) | 2.22847844 |
92 | Chronic diarrhea (HP:0002028) | 2.20487574 |
93 | Keratoconjunctivitis sicca (HP:0001097) | 2.20462446 |
94 | Anorexia (HP:0002039) | 2.19895248 |
95 | Myocardial infarction (HP:0001658) | 2.19394597 |
96 | Chest pain (HP:0100749) | 2.18089728 |
97 | Abnormality of the pleura (HP:0002103) | 2.16997838 |
98 | Combined immunodeficiency (HP:0005387) | 2.15935498 |
99 | Polyneuropathy (HP:0001271) | 2.14108815 |
100 | Amaurosis fugax (HP:0100576) | 2.13251119 |
101 | Cheilitis (HP:0100825) | 2.10639548 |
102 | Severe combined immunodeficiency (HP:0004430) | 2.10115735 |
103 | Recurrent sinusitis (HP:0011108) | 2.10025516 |
104 | Joint swelling (HP:0001386) | 2.09942500 |
105 | Glomerulopathy (HP:0100820) | 2.08731504 |
106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07672281 |
107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07253328 |
108 | Verrucae (HP:0200043) | 2.05906358 |
109 | Papilloma (HP:0012740) | 2.05906358 |
110 | Thyroiditis (HP:0100646) | 2.05301808 |
111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04969266 |
112 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04969266 |
113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04969266 |
114 | Mucopolysacchariduria (HP:0008155) | 2.04161184 |
115 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04161184 |
116 | Vertigo (HP:0002321) | 2.04121929 |
117 | Disinhibition (HP:0000734) | 2.02696545 |
118 | Keratoconjunctivitis (HP:0001096) | 2.00515656 |
119 | Episodic fever (HP:0001954) | 1.99564957 |
120 | * Basal ganglia calcification (HP:0002135) | 1.96893382 |
121 | Epistaxis (HP:0000421) | 1.96740223 |
122 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96617243 |
123 | Arthralgia (HP:0002829) | 1.95929213 |
124 | Malnutrition (HP:0004395) | 1.95614294 |
125 | Abnormality of the peritoneum (HP:0002585) | 1.94432979 |
126 | Prostate neoplasm (HP:0100787) | 1.94303319 |
127 | Increased serum ferritin (HP:0003281) | 1.93910678 |
128 | B lymphocytopenia (HP:0010976) | 1.93836806 |
129 | Thrombophlebitis (HP:0004418) | 1.90669395 |
130 | Abnormality of the prostate (HP:0008775) | 1.88815809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.40866673 |
2 | TYK2 | 3.88275167 |
3 | MAP3K14 | 3.42006189 |
4 | JAK3 | 3.27327799 |
5 | BLK | 3.09630825 |
6 | IKBKE | 3.03550042 |
7 | TBK1 | 2.93419041 |
8 | TXK | 2.70460462 |
9 | IRAK4 | 2.62892458 |
10 | JAK1 | 2.57165381 |
11 | PRPF4B | 2.53503951 |
12 | FGFR4 | 2.51224452 |
13 | KIT | 2.45540341 |
14 | IKBKB | 2.14276136 |
15 | STK10 | 2.14225063 |
16 | ZAP70 | 2.12133252 |
17 | IRAK3 | 2.03790665 |
18 | MAP3K13 | 1.97484103 |
19 | FGFR3 | 1.91745090 |
20 | ERN1 | 1.91639724 |
21 | RIPK4 | 1.89192472 |
22 | CSK | 1.73727027 |
23 | SYK | 1.56842394 |
24 | ITK | 1.52501899 |
25 | EPHB1 | 1.50018163 |
26 | BTK | 1.50005984 |
27 | HCK | 1.45136162 |
28 | LCK | 1.42626286 |
29 | CHUK | 1.34168807 |
30 | MAP3K10 | 1.32850919 |
31 | CSF1R | 1.32838212 |
32 | RPS6KA4 | 1.32266703 |
33 | TNK2 | 1.30172616 |
34 | TEC | 1.26097725 |
35 | GRK6 | 1.23394490 |
36 | TGFBR2 | 1.23239018 |
37 | EPHA3 | 1.21514132 |
38 | PIM2 | 1.19916943 |
39 | LRRK2 | 1.16296319 |
40 | GRK7 | 1.14451724 |
41 | CAMKK2 | 1.12017707 |
42 | PIM1 | 1.11802778 |
43 | PIK3CG | 1.11588413 |
44 | JAK2 | 1.09057920 |
45 | CDK12 | 1.08322539 |
46 | NEK9 | 1.06326837 |
47 | MST4 | 1.06062800 |
48 | NME2 | 1.05514655 |
49 | TAOK1 | 1.04689125 |
50 | MARK3 | 1.02978542 |
51 | MAP2K3 | 1.00019632 |
52 | NLK | 0.99914696 |
53 | LYN | 0.99224085 |
54 | MAP3K1 | 0.98589495 |
55 | CDC42BPA | 0.97749924 |
56 | PBK | 0.96129242 |
57 | TRIB3 | 0.93105507 |
58 | TTN | 0.91074547 |
59 | YES1 | 0.89162161 |
60 | PDPK1 | 0.87335299 |
61 | CDK19 | 0.86446739 |
62 | STK4 | 0.81897971 |
63 | IRAK1 | 0.81353939 |
64 | MARK2 | 0.80994279 |
65 | TAOK3 | 0.80781290 |
66 | FES | 0.80554951 |
67 | PRKCQ | 0.79674949 |
68 | KSR2 | 0.78757912 |
69 | MAPK7 | 0.77952425 |
70 | CLK1 | 0.74230393 |
71 | MAP3K2 | 0.70845502 |
72 | MAPK12 | 0.70769918 |
73 | STK3 | 0.70011039 |
74 | SIK2 | 0.69804954 |
75 | TAOK2 | 0.68447195 |
76 | PTK6 | 0.65531461 |
77 | STK24 | 0.65124048 |
78 | SGK3 | 0.64190488 |
79 | MAP3K6 | 0.62744182 |
80 | CAMKK1 | 0.60982833 |
81 | BMPR2 | 0.60584450 |
82 | TRPM7 | 0.60151060 |
83 | KDR | 0.60078687 |
84 | CDK6 | 0.59838983 |
85 | FGR | 0.57194350 |
86 | PKN2 | 0.56341200 |
87 | EGFR | 0.52817239 |
88 | ALK | 0.51149043 |
89 | MOS | 0.50514110 |
90 | ABL1 | 0.49398797 |
91 | SGK2 | 0.48668062 |
92 | PRKCH | 0.48312856 |
93 | CDK4 | 0.47794640 |
94 | MAP3K5 | 0.45157926 |
95 | MAP3K3 | 0.45125514 |
96 | PTK2B | 0.44495249 |
97 | RPS6KL1 | 0.43963087 |
98 | RPS6KC1 | 0.43963087 |
99 | BMX | 0.43757980 |
100 | EEF2K | 0.43668898 |
101 | RPS6KA5 | 0.41120239 |
102 | SIK3 | 0.40599315 |
103 | DMPK | 0.40148289 |
104 | MATK | 0.39702656 |
105 | MAP3K7 | 0.39078377 |
106 | EIF2AK2 | 0.37943443 |
107 | MAP3K8 | 0.37870959 |
108 | NUAK1 | 0.37447316 |
109 | FLT3 | 0.35536656 |
110 | PRKD2 | 0.34411755 |
111 | RIPK1 | 0.34404248 |
112 | MAPKAPK2 | 0.33779934 |
113 | RET | 0.33521314 |
114 | PRKCD | 0.33509682 |
115 | ACVR1B | 0.33286058 |
116 | STK11 | 0.32721048 |
117 | NEK6 | 0.32629029 |
118 | CAMK4 | 0.32421919 |
119 | BRD4 | 0.32309773 |
120 | HIPK2 | 0.30834744 |
121 | PDGFRB | 0.30569251 |
122 | CAMK1D | 0.29687560 |
123 | RPS6KA6 | 0.28888899 |
124 | PDK1 | 0.26385894 |
125 | CDK9 | 0.25712451 |
126 | FYN | 0.25532572 |
127 | MAPK11 | 0.25456143 |
128 | INSR | 0.25268132 |
129 | IRAK2 | 0.25102910 |
130 | MAP3K11 | 0.23913298 |
131 | NEK2 | 0.19356982 |
132 | IGF1R | 0.18572251 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01183597 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94623499 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85955814 |
4 | Measles_Homo sapiens_hsa05162 | 2.61762168 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56366759 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.51446470 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.49416385 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37527909 |
9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.31440291 |
10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31128112 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28236471 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27217980 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16360966 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09783949 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04528482 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.99741881 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96738009 |
18 | Influenza A_Homo sapiens_hsa05164 | 1.91258126 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.81269668 |
20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.79477451 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76448639 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.74224024 |
23 | Pertussis_Homo sapiens_hsa05133 | 1.73410131 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70220283 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68839609 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68578047 |
27 | Malaria_Homo sapiens_hsa05144 | 1.67496249 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.63091378 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62505013 |
30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57036800 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51704950 |
32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50992482 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.48667540 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.42597842 |
35 | Shigellosis_Homo sapiens_hsa05131 | 1.41956946 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41460723 |
37 | Asthma_Homo sapiens_hsa05310 | 1.40027012 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28003188 |
39 | Hepatitis C_Homo sapiens_hsa05160 | 1.27566052 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19909139 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19240628 |
42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17741137 |
43 | Salmonella infection_Homo sapiens_hsa05132 | 1.17697021 |
44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15929828 |
45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14971033 |
46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11994025 |
47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05998924 |
48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03833420 |
49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00017713 |
50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97384166 |
51 | Lysosome_Homo sapiens_hsa04142 | 0.95285752 |
52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91654889 |
53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86577318 |
54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85406105 |
55 | Platelet activation_Homo sapiens_hsa04611 | 0.85307992 |
56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83862181 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81814668 |
58 | Phagosome_Homo sapiens_hsa04145 | 0.80897942 |
59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78034039 |
60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76931956 |
61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74321774 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74297573 |
63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73139439 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72088735 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62705593 |
66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60744960 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57972428 |
68 | Amoebiasis_Homo sapiens_hsa05146 | 0.57966752 |
69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57755984 |
70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56040975 |
71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52960247 |
72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52303356 |
73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51483639 |
74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50253214 |
75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49984920 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47882249 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47526857 |
78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46781427 |
79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45799744 |
80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45082329 |
81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43997898 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41428646 |
83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40335212 |
84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40169950 |
85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39698415 |
86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39332765 |
87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39077954 |
88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38589172 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38273721 |
90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37574745 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.36690542 |
92 | Insulin resistance_Homo sapiens_hsa04931 | 0.35172307 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.32774143 |
94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31709584 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30461415 |
96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29549793 |
97 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28145227 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27538489 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27439719 |
100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.25783548 |
101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.24945406 |
102 | Adherens junction_Homo sapiens_hsa04520 | 0.24794631 |
103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24728679 |
104 | Focal adhesion_Homo sapiens_hsa04510 | 0.23621437 |
105 | Base excision repair_Homo sapiens_hsa03410 | 0.23547106 |
106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23485835 |
107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.22450864 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21347583 |
109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20245224 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19082597 |
111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17341037 |
112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16073522 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15422158 |
114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.14226065 |